Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer, Allergan get request for additional information from FTC

[Reuters] – Pfizer Inc and Allergan Plc said they have received a request for additional information from the U.S. Federal Trade Commission with respect to their merger. The FTC’s request for information extends the waiting period required under antitrust rules to 30 days, after the companies have provided the information. Read more on this. Pfizer Inc. (PFE) , with a current market cap of $186.19B, began trading this morning at $30.18. Today, shares have traded between $30.01 and $30.21 per share with a one year range of $28.25 to $36.46. PFE shares are currently priced at 13.00x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -5.78x earnings multiple for the same period. The company pays shareholders $1.20 per share annually in dividends, yielding 3.99%. In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $0.54 per share, which would be $0.03 better than the year-ago quarter and a $0.03 sequential decrease. The full-year EPS estimate is $2.29 which would be a $0.09 improvement than last year’s full-year earnings. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $11.90 Billion. If realized, that would be a 9.58% increase over the year-ago quarter. Recently, Sun Trust Rbsn Humphrey upgraded PFE from Reduce to Neutral (Nov 25, 2015). Previously, Morgan Stanley upgraded PFE from Equal-Weight to Overweight. When considering if perhaps the stock is under or overvalued, the average price target is $38.81, which is 28.60% above where the stock opened this morning. See more in (NYSE:PFE) Similar Articles: Market Update (NYSE:AGN): Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combination Stock Update: Pfizer Inc (NYSE:PFE) – Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO Stock Update (NYSE:PFE): Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference